http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101428018-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3519ea242d97a904badff9271f63de45
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba53ae6f806e2b82702d287e37602db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32e0b0b23a0ae186a7cbcb712324199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774d43b1c3dfffeb1f774c94baedb684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f24413b15793f51cdf1db3e748e8eae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a410727fa3bbd8c3c9b3060b0cb130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504aef4ec6bb8b085b6b81da734697b7
publicationDate 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101428018-B1
titleOfInvention Orally disintegrating tablet containing aripiprazole and manufacturing method thereof
abstract The present invention relates to an orally disintegrating tablets comprising aripiprazole and a solid dispersion of aripiprazole and a hydrophilic polymer, more preferably a three-component solid dispersion of aripiprazole, a specific hydrophilic polymer and a sugar alcohol (preferably mannitol) Is used. The aripiprazole oral disintegration tablet according to the present invention has improved dissolution and absorption properties and is excellent in taste, foreign substance, and the like.
priorityDate 2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090008307-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251

Total number of triples: 54.